Source: International Congress 2018 – French Programme 2018: Part II



Rating:

Share or cite this content

Citations should be made in the following way:
X. Jais (Le Kremlin-Bicêtre, France). Thrombo-embolic pulmonary hypertension: which treatment should we choose? / Hypertension pulmonaire thrombo-embolique: quel traitement choisir ?. International Congress 2018 – French Programme 2018: Part II

Member's Comments

No comment yet.

Related content which might interest you: Chronic post-embolic pulmonary hypertension: a new target for medical therapies?}, Source: Eur Respir Rev 2013; 22: 258-264 Year: 2013 Treating pulmonary hypertension in COPD: where do we start? Source: Eur Respir J 2008; 32: 541-542 Year: 2008 Diagnosis and treatment of pulmonary hypertension in COPD patients: how far should we go? Source: International Congress 2019 – Lung vessels in COPD: it is time to take them seriously! Year: 2019 Treatment of pulmonary hypertension due to COPD: can we really hope in better? Source: Eur Respir J 2005; 26: Suppl. 49, 562s Year: 2005 “Rehab for all!” Is it too early in pulmonary arterial hypertension? Source: Eur Respir J, 54 (5) 1901558; 10.1183/13993003.01558-2019 Year: 2019 Goal-oriented therapy in paediatric pulmonary arterial hypertension: are we ready? Source: Eur Respir J 2014; 44: 1404-1407 Year: 2014 Chronic thromboembolic pulmonary hypertension: do we need a new definition? Source: Eur Respir J 2014; 44: 1401-1403 Year: 2014 Different treatment modalities in chronic thromboembolic pulmonary hypertension: how to combine them? Source: International Congress 2017 – Open questions in pulmonary vascular diseases Year: 2017 Interventional treatment of pulmonary hypertension: where are we now? Source: Virtual Congress 2020 – Breathing disorders and cardiovascular diseases Year: 2020 Cure pulmonary arterial hypertension associated with HIV (PAH-HIV)? … Toward an answer Source: Annual Congress 2011 - Treatment of human pulmonary hypertension Year: 2011 Cancer treatment in pulmonary hypertension: cause or cure? Source: Annual Congress 2013 –Ceremony for the ERS Award for Lifetime Achievement in Pulmonary Arterial Hypertension (financially supported by Actelion) followed by Symposium: Drug-induced pulmonary arterial hypertension Year: 2013 Newly diagnosed patients with chronic thromboembolic pulmonary hypertension and PASP<50 mmHg. Do they need pulmonary endarterectomy? Source: Annual Congress 2005 - News about pulmonary embolism Year: 2005 Pulmonary embolism and pulmonary hypertension - is our follow up adequate? Source: Eur Respir J 2005; 26: Suppl. 49, 270s Year: 2005 Chronic thromboembolic pulmonary hypertension and splenectomy: Is there a link? Source: Eur Respir J 2003; 22: Suppl. 45, 218s Year: 2003 Pulmonary hypertension in the elderly: a different disease? Source: Breathe 2016; 12: 43-49 Year: 2016 Is survival in patients with severe group 3 pulmonary hypertension influenced by targeted therapy? Source: International Congress 2015 – Pulmonary hypertension: novel clinical insights Year: 2015 Image-based recommendations for the evaluation of pulmonary embolism and arterial hypertension: what? when? how? Source: Virtual Congress 2020 – Image-based guidelines and recommendations in respiratory diseases Year: 2020 Pulmonary arterial hypertension among elderly patients: an emerging problem? Source: Annual Congress 2007 - Pulmonary hypertension in the clinic Year: 2007 Acute vasodilator testing in idiopathic pulmonary arterial hypertension: must we take NO for the answer? Source: Eur Respir J 2009; 33: 1247-1249 Year: 2009